DBV Technologies (DBVT) Assets Average (2016 - 2026)

DBV Technologies (DBVT) reported Assets Average of $250.0 million for Q1 2026, up 330.3% year-over-year from $58.1 million in Q1 2025, and up 45.3% quarter-over-quarter from $172.1 million in Q4 2025.

DBV Technologies (DBVT) Assets Average (2016 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 10 years of Assets Average data on file, last reported at $250.0 million in Q1 2026.

  • Assets Average for Q1 2026 came in at $250.0 million, up 330.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $250.0 million (up 330.3% YoY), and the FY2025 annual result was $149.7 million, up 20.4% from the prior year.
  • Assets Average advanced to $250.0 million in Q1 2026 per DBVT's latest filing, from $172.1 million in the prior quarter.
  • Over five years, Assets Average peaked at $266.5 million in Q3 2022 and troughed at $58.1 million in Q1 2025.
  • A 5-year average of $169.6 million and a median of $172.1 million in 2025 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2025 and 2026: Assets Average slumped 64.66% in 2025, then jumped 330.3% in 2026.
  • A 5-year view of Assets Average shows it stood at $247.3 million in 2022, then decreased by 24.64% to $186.4 million in 2023, then tumbled by 57.42% to $79.4 million in 2024, then jumped by 116.87% to $172.1 million in 2025, then jumped by 45.3% to $250.0 million in 2026.
  • Business Quant data shows DBVT's Assets Average at $250.0 million in Q1 2026, $172.1 million in Q4 2025, and $127.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 33.42 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.91 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13.04 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.72 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 26.03 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 40.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.06 Bn
9 Abivax 91.96 Bn 91.96 Bn - 660.38 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 250.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 250.05 Mn
Dec 31, 2025 172.10 Mn
Sep 30, 2025 126.96 Mn
Jun 30, 2025 97.00 Mn
Mar 31, 2025 58.11 Mn
Dec 31, 2024 79.36 Mn
Sep 30, 2024 103.62 Mn
Jun 30, 2024 130.04 Mn
Mar 31, 2024 164.44 Mn
Dec 31, 2023 186.38 Mn
Sep 30, 2023 203.65 Mn
Jun 30, 2023 225.22 Mn
Mar 31, 2023 239.72 Mn
Dec 31, 2022 247.32 Mn
Sep 30, 2022 266.55 Mn
Jun 30, 2022 201.28 Mn
Mar 31, 2022 132.15 Mn
Dec 31, 2021 158.82 Mn
Sep 30, 2021 185.75 Mn
Jun 30, 2021 210.99 Mn